Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limbo Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
PET Scans Reveal Vascular Inflammation In giant cell arteritis, imaging confirmed clinical response Jan 07, 2021
Who Flares When SLE Patients Stop Hydroxychloroquine? Flares more likely among minorities, younger patients, and those taking steroids Jan 05, 2021
Ozanimod a Winner in Ulcerative Colitis S1P receptor modulator effective for both induction and maintenance Dec 10, 2020
Colchicine Approval Took a Huge Toll on CMS As centuries-old drug is explored for COVID-19, study details the price of approval Nov 30, 2020
TYK2 Inhibition Promising in Psoriatic Arthritis Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
More Evidence Early Mortality Persists in IBD Canadian study shows treatment advances haven't erased lifespan deficit Nov 09, 2020
COVID Complications Common with Rheumatic Disease Adverse outcomes included acute kidney injury and congestive heart failure Nov 08, 2020
Rinvoq for RA: Benefits Persist Beyond 1 Year Manufacturer's extension study shows no loss of clinical response Nov 06, 2020
Nonsteroidal Topical, Nanodrug Active in Psoriasis Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
Upadacitinib, Abatacept Go Head to Head in RA And the winner is... both, depending on whether efficacy or safety is the main criterion Oct 14, 2020
Depression and Biologic Use in Arthritis: Chicken or Egg? Relationship appears to be bi-directional, researchers say Oct 02, 2020
Novel Biologic Promising in Mid-Stage Scleroderma Trial Significant differences seen at week 24 for the agent versus placebo on background therapy Sep 28, 2020
COVID-19 Storms: Bradykinin In, Cytokine Out? Papers poke holes in cytokine storm as gene expression study offers a new theory Sep 11, 2020
Mepolizumab Offers Relief for Chronic Sinus Trouble Anti-IL5 biologic cut polyp size, need for surgery in chronic rhinosinusitis with nasal polyps Sep 10, 2020
Capsaicin Injection Improves Knee OA Pain Investigational treatment targets capsaicin receptor to inactivate local pain fibers Sep 06, 2020
Novel Form of Muscle Relaxant Shows Benefit Tolperisone may help pain from acute back spasms without causing drowsiness Sep 05, 2020
Joint Effusion Protective in Hand OA Unlike synovitis, which was linked with both pain and progression Sep 03, 2020
Al Roker's Shoulder Replacement "Today" co-host and weatherman battles osteoarthritis pain Aug 25, 2020
Lupus Anticoagulant Tied to COVID Thrombosis Small study suggests consideration of therapeutic anticoagulation Aug 12, 2020
Few Risks for Sjogren's Patients With Joint Surgery Transfusion rates raised but no increase for infection, revision, or mortality Jul 30, 2020
Tocilizumab Raises GI Risks in Rheumatoid Arthritis Double the risk of one rare but potentially deadly event compared with use of TNF inhibitors, large Swedish study found Jul 22, 2020
Targeting IL-23 Relieves Multiple Symptoms in PsA Both enthesitis and dactylitis improved with guselkumab treatment in psoriatic arthritis Jul 21, 2020
Colchicine Shows Promise in COVID-19 Patients, With Caveats Clinical effects need further investigation, authors urge Jun 24, 2020
Muscle Relaxer Rx Doubled Over 12-Year Span Spike in prescriptions among older adults particularly concerning, researchers note Jun 24, 2020
Gout: Methotrexate May Enhance Pegloticase Response In small study, uric acid levels were reduced to near undetectable levels in almost 80% of patients Jun 09, 2020
Psoriatic Arthritis: Outcomes Similar for Cosentyx and Humira Primary endpoint of superiority for secukinumab over adalimumab not met in a phase IIIb trial Jun 08, 2020
Voclosporin Beats Standard of Care in Lupus Nephritis High rates of response seen even among difficult-to-treat Hispanic patients Jun 05, 2020
Avacopan Superior to Steroids in ANCA Vasculitis Greater rates of remission and improved renal function seen with oral C5a receptor antagonist Jun 04, 2020
Another IL-6 Blocker Succeeds in Rheumatoid Arthritis Effective in patients with moderately to severely active disease in a phase III trial Jun 03, 2020
EULAR 2020: What to Expect Cancelled due to pandemic but extensive menu of virtual learning planned Jun 02, 2020
High-Dose Vitamin D Disappoints for Preventing Crohn’s Recurrence No benefit seen despite substantial increase in serum 25-OH-D May 27, 2020
Biologics Don't Increase Melanoma Risk... Probably Meta-analysis offers some reassurance, but leaves room for doubt May 20, 2020
IL-17A Blockers Succeed in Spine Disease Secukinumab and ixekizumab best placebo for ankylosing spondylitis May 13, 2020
Study Backs Cytokine Targeting for COVID-19 Tx Interrupting host inflammatory response shows promise May 08, 2020
CellCept Succeeds in ANCA Vasculitis Benefits, however, for only one serotype of antineutrophil cytoplasmic antibodies, study found May 07, 2020
Do You Believe in HCQ for COVID-19? It Will Break Your Heart Milton Packer believes advocacy of the drug is practicing politics, not medicine May 06, 2020
Rheumatoid Arthritis: Biologic Dose Cuts Feasible Majority of patients who achieved remission, low disease activity could lower biologic intake without flaring Apr 30, 2020
